A detailed history of Janus Henderson Group PLC transactions in Integra Lifesciences Holdings Corp stock. As of the latest transaction made, Janus Henderson Group PLC holds 33,756 shares of IART stock, worth $587,354. This represents 0.0% of its overall portfolio holdings.

Number of Shares
33,756
Previous 34,105 1.02%
Holding current value
$587,354
Previous $1.21 Million 18.69%
% of portfolio
0.0%
Previous 0.0%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$23.14 - $34.72 $8,075 - $12,117
-349 Reduced 1.02%
33,756 $983,000
Q4 2023

Feb 14, 2024

SELL
$34.21 - $44.59 $2,155 - $2,809
-63 Reduced 0.18%
34,105 $1.49 Million
Q3 2023

Nov 14, 2023

SELL
$37.8 - $45.97 $302 - $367
-8 Reduced 0.02%
34,168 $1.3 Million
Q2 2023

Aug 14, 2023

SELL
$37.95 - $58.98 $63.4 Million - $98.5 Million
-1,669,911 Reduced 97.99%
34,176 $1.41 Million
Q1 2023

May 15, 2023

SELL
$52.61 - $60.49 $49.1 Million - $56.5 Million
-933,972 Reduced 35.4%
1,704,087 $97.8 Million
Q4 2022

Feb 14, 2023

SELL
$42.17 - $58.6 $22.5 Million - $31.3 Million
-534,479 Reduced 16.85%
2,638,059 $148 Million
Q3 2022

Nov 14, 2022

SELL
$42.28 - $57.17 $4.55 Million - $6.15 Million
-107,610 Reduced 3.28%
3,172,538 $134 Million
Q2 2022

Aug 15, 2022

SELL
$53.86 - $66.52 $147,791 - $182,530
-2,744 Reduced 0.08%
3,280,148 $177 Million
Q1 2022

May 16, 2022

SELL
$62.86 - $69.24 $29.3 Million - $32.2 Million
-465,392 Reduced 12.42%
3,282,892 $211 Million
Q4 2021

Feb 14, 2022

SELL
$62.47 - $73.25 $24.7 Million - $29 Million
-395,441 Reduced 9.54%
3,748,284 $251 Million
Q3 2021

Nov 16, 2021

SELL
$64.97 - $76.19 $32.4 Million - $38 Million
-499,344 Reduced 10.75%
4,143,725 $284 Million
Q2 2021

Aug 16, 2021

SELL
$66.79 - $76.63 $941,338 - $1.08 Million
-14,094 Reduced 0.3%
4,643,069 $317 Million
Q1 2021

May 17, 2021

BUY
$62.63 - $71.15 $2.19 Million - $2.49 Million
35,000 Added 0.76%
4,657,163 $322 Million
Q4 2020

Feb 16, 2021

BUY
$43.31 - $66.55 $24.8 Million - $38.1 Million
572,291 Added 14.13%
4,622,163 $300 Million
Q3 2020

Nov 16, 2020

SELL
$43.33 - $51.72 $6.3 Million - $7.52 Million
-145,314 Reduced 3.46%
4,049,872 $191 Million
Q2 2020

Aug 14, 2020

SELL
$41.42 - $55.57 $4.59 Million - $6.15 Million
-110,740 Reduced 2.57%
4,195,186 $197 Million
Q1 2020

May 14, 2020

SELL
$36.67 - $61.04 $253,793 - $422,457
-6,921 Reduced 0.16%
4,305,926 $192 Million
Q4 2019

Feb 18, 2020

BUY
$55.73 - $62.49 $60.5 Million - $67.9 Million
1,086,385 Added 33.67%
4,312,847 $251 Million
Q3 2019

Nov 14, 2019

SELL
$53.29 - $64.59 $1.19 Million - $1.45 Million
-22,408 Reduced 0.69%
3,226,462 $194 Million
Q2 2019

Jul 31, 2019

BUY
$46.45 - $55.85 $17.4 Million - $21 Million
375,546 Added 13.07%
3,248,870 $181 Million
Q1 2019

Apr 30, 2019

BUY
$42.97 - $57.33 $29.6 Million - $39.5 Million
688,761 Added 31.53%
2,873,324 $160 Million
Q4 2018

Feb 06, 2019

BUY
$42.62 - $64.51 $7.48 Million - $11.3 Million
175,432 Added 8.73%
2,184,563 $98.5 Million
Q3 2018

Nov 09, 2018

BUY
$57.63 - $65.87 $2.47 Million - $2.82 Million
42,790 Added 2.18%
2,009,131 $132 Million
Q2 2018

Aug 10, 2018

BUY
$54.05 - $67.23 $19.7 Million - $24.6 Million
365,254 Added 22.81%
1,966,341 $127 Million
Q1 2018

May 14, 2018

SELL
$46.55 - $57.38 $124,055 - $152,917
-2,665 Reduced 0.17%
1,601,087 $88.6 Million
Q4 2017

Feb 09, 2018

SELL
$46.22 - $51.77 $19.9 Million - $22.3 Million
-431,536 Reduced 21.2%
1,603,752 $76.8 Million
Q3 2017

Nov 14, 2017

SELL
$47.8 - $53.63 $985,874 - $1.11 Million
-20,625 Reduced 1.0%
2,035,288 $0
Q2 2017

Aug 17, 2017

BUY
N/A
2,055,913
2,055,913 $112 Million

Others Institutions Holding IART

About INTEGRA LIFESCIENCES HOLDINGS CORP


  • Ticker IART
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 83,518,200
  • Market Cap $1.45B
  • Description
  • Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, and general surgery. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including...
More about IART
Track This Portfolio

Track Janus Henderson Group PLC Portfolio

Follow Janus Henderson Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Janus Henderson Group PLC with notifications on news.